Turnstone Biologics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TSBX annual revenue was $0.0, with -100% growth year-over-year.
TSBX past revenue growth
How has TSBX's revenue growth performed historically?
Turnstone Biologics (NASDAQ: TSBX) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Turnstone Biologics's revenue was $0.00.
What was Turnstone Biologics's revenue in 2024?
Turnstone Biologics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
How much does Turnstone Biologics make in a day?
Based on Turnstone Biologics annual revenue for the past three years, TSBX makes an average of $84,571.69 per day.
What was Turnstone Biologics's annual revenue growth in the past year?
As of Q2 2025, Turnstone Biologics's revenue has grown -100% year over year. This is 597.69 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Turnstone Biologics's revenue in the past year totaled $0.00.
How much does Turnstone Biologics make in a year?
Turnstone Biologics's revenue by year for the past three years is:
Turnstone Biologics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
Turnstone Biologics's annual revenue for Dec 31, 2023 was $19.31 million, a 73.66% decrease from 2022.
Turnstone Biologics's annual revenue for 2022 was $73.30 million, a 27.64% decrease from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.